# clm_155A4F299072

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 11,025,300,000 United States dollar  
valid_from: 2020-12-31  
valid_to: 2021-03-31  
published: 2021-02-08  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_51B4B52D2498  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 11,025,300,000 United States dollar", as of 2020-12-31 (until 2021-03-31). Claim clm_155A4F299072, https://asof.is/claim/clm_155A4F299072, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-K FY2020, filed 2021-02-08  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422021000008/0001804220-21-000008-index.htm (primary, SEC EDGAR 10-K FY2020, published 2021-02-08)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 10,125,500,000 United States dollar | valid 2020-09-30 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_155A4F299072](/claim/clm_155A4F299072.md) | [clm_3A63F9598C82](/claim/clm_3A63F9598C82.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.